Article Text

Download PDFPDF
CASE REPORT
Salvage therapy for acute severe ulcerative colitis during pregnancy
  1. Manjri Raval1,
  2. Matthew C Choy2,3,
  3. Peter De Cruz2,3
  1. 1 General Medicine, Austin Health, Heidelberg, Victoria, Australia
  2. 2 Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
  3. 3 The University of Melbourne, Melbourne, Victoria, Australia
  1. Correspondence to Dr Peter De Cruz, ppdecruz{at}gmail.com

Summary

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with an age of onset that affects young people during the peak of their reproductive years. Management of flares of disease during pregnancy can be complex and there are few case reports of pregnant women with acute severe ulcerative colitis (ASUC). We present the case of a 31-year-old pregnant woman who at 16 weeks gestation developed ASUC in the context of primary non-response to infliximab therapy. She subsequently underwent an emergency laparoscopic colectomy after failing to respond to hydrocortisone and cyclosporine salvage therapy. Her pregnancy was further complicated by HELLP (Haemolysis, Elevated liver enzymes and Low Platelets) syndrome resulting in premature delivery at 27 weeks gestation. This case highlights the management issues involved in ASUC during pregnancy and the assessment of disease activity, use of salvage therapies, and provides a framework to approach this complex medical emergency.

  • ulcerative colitis
  • pregnancy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MR: performed literature search, involved in acquisition of information for the case report, prepared initial draft and manuscript of case report. PDC and MCC: provided expertise, intellectual content and critically reviewed the draft to assist with finalisation of draft manuscript for submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.